Ozempic and Mounjaro: The Weight Loss Benefits of GLP-1 Agonists

The GLP-1 agonist drugs, Ozempic and Mounjaro, have gained significant attention for their ability to not only treat diabetes but also cause significant and sustained weight loss. This remarkable effect can be attributed to their impact on incretin hormones, specifically glucagon-like peptide-1 (GLP-1).

GLP-1 is a hormone released by the intestine in response to food intake. It plays a crucial role in regulating blood sugar levels by stimulating insulin secretion and inhibiting glucagon release. Additionally, GLP-1 slows down gastric emptying, leading to increased satiety and reduced appetite.

Ozempic and Mounjaro are designed to mimic the actions of GLP-1. When these drugs are administered, they bind to GLP-1 receptors in different parts of the body, including the pancreas, brain, and stomach. By activating these receptors, they enhance the effects of GLP-1, resulting in several beneficial outcomes.

One of the primary effects is the promotion of insulin secretion from pancreatic beta cells. This leads to improved glucose uptake by cells and a decrease in blood sugar levels. Additionally, GLP-1 agonists suppress the release of glucagon, which is responsible for increasing blood sugar levels. By blunting glucagon’s action, these drugs help maintain a more stable glucose balance.

In regards to weight loss, GLP-1 agonists exert multiple effects. They delay gastric emptying, which means food stays in the stomach for a longer duration, creating a feeling of fullness and reducing the urge to eat. Moreover, GLP-1 agonists act on the hypothalamus in the brain, helping to regulate appetite and satiety signals.

Furthermore, GLP-1 agonists increase energy expenditure and promote fat burning. They enhance the breakdown of stored fat while simultaneously decreasing the absorption of fat from the gastrointestinal tract. These combined mechanisms contribute to substantial weight loss over time.

It is worth noting that the weight loss achieved with GLP-1 agonist drugs varies from person to person. However, studies have demonstrated that patients using Ozempic or Mounjaro experience more significant weight loss compared to other diabetes medications.

In conclusion, the GLP-1 agonist drugs, such as Ozempic and Mounjaro, are effective treatments for diabetes while also offering the substantial benefit of promoting significant and sustained weight loss. By influencing incretin hormones, these medications provide a comprehensive approach to managing both blood sugar levels and body weight.

Bupropion + naltrexone is an effective weight loss drug. How does it work and what effects can be achieved?

Mysimba for weight loss – what is this drug?

Mysimba is a medication used for weight management in adults who have a body mass index (BMI) of 30 or more, or a BMI of 27 or more with weight-related conditions. It contains a combination of two active ingredients: bupropion and naltrexone. Bupropion is an antidepressant and smoking cessation aid, while naltrexone is primarily used to manage alcohol and opioid dependence. Together, they work to suppress appetite and reduce cravings, helping individuals achieve sustainable weight loss.

How does bupropion + naltrexone work?

Bupropion + naltrexone work synergistically to promote weight loss. Bupropion acts on certain brain chemicals to decrease appetite and enhance the feeling of fullness. It also increases the body’s energy expenditure. Naltrexone, on the other hand, helps to reduce food cravings by blocking certain receptors involved in addiction and reward pathways. The combination of these two medications helps to control food intake and support weight management efforts.

Bupropion + naltrexone for weight loss – indications

Bupropion + naltrexone is indicated for use in adults with a body mass index (BMI) of 30 or greater, or in those with a BMI of 27 or greater with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol). This medication should be used as part of a comprehensive weight management program that includes a reduced-calorie diet and increased physical activity.

Bupropion + naltrexone for weight loss – dosage

The recommended starting dose of bupropion + naltrexone is one tablet containing 8 mg of naltrexone and 90 mg of bupropion, taken orally once per day. The dose is gradually increased over time to reach a maintenance dose of two tablets (16 mg of naltrexone and 180 mg of bupropion) taken in the morning and evening. It is important to follow the prescribed dosage and instructions provided by your healthcare professional.

The effectiveness of Mysimba. How much weight can you lose?

The effectiveness of Mysimba varies from person to person. Clinical studies have shown that,

Bupropion plus naltrexone is an effective weight loss pill

Mysimba is one of the few prescription weight loss pills available. It contains 7.2 mg of naltrexone and 78 mg of bupropion as active components. B propion is a norepinephrine and dopamine reuptake inhibitor that is selective. It is a prescription medicine used to treat depression and nicotinism. N- altrexone, on the other hand, is a codeine analogue and an opioid inverse agonist. It is utilised in the treatment of alcoholism and opiate addiction. Neither drug is habit-forming.

Read More at Munaeem’s Blog

How does oral Semaglutide differ from an injectable weight loss drug?

Semaglutide is one of the most sought-after drugs in the world today. It aids in the fight against obesity and diabetes. It is available for purchase as injections (Ozempic) or tablets (Rybelsus). However, the injectable drug is more popular than the oral drug. Are they extremely dissimilar to one another?

Semaglutide is a medication for type 2 diabetes, but due to its significant impact on weight loss, it has become one of the most sought-after drugs worldwide, and not just among diabetics (more: dangerous trend with diabetes injections). available on prescription only. Although the official indications for semaglutide include the treatment of diabetes, it is known that the drug is also prescribed off-label to obese patients. Due to the high demand, pharmacies continue to lack it.

a popular weight loss drug

Two medicines containing the active substance semaglutide are available on the market:

  • Ozempic—given as an injection once a week,
  • Rybelsus – administered in the form of a tablet orally daily.

Even though the active ingredient in both medicines is the same, Ozempic is more popular, and it is mostly this medicine that is not available in pharmacies. Are semglutide tablets less effective? The similarities and differences between the two drugs were examined.

How does semaglutide work?

Ozempic and Rybelsus’ active ingredient, semgalutide, is used to treat diabetes and obesity. It works by mimicking the incretin hormone glucagon-like peptide 1 (GLP-1), which the intestines secrete after a meal. Consequently, there is a rise in insulin secretion, which regulates glucose levels. Importantly, these drugs only increase insulin levels when glucose levels are elevated, making their use associated with a low risk of hypoglycemia (i.e., an excessive and dangerous drop in sugar). Consequently, these medications are safe for diabetic patients.

Benefits of using semaglutide:

  • lowers blood glucose levels,
  • lowers body weight (more:  slimming injections: how much can you lose? ),
  • reduces appetite, 
  • has a cardioprotective effect, which means it protects against atherosclerosis and lowers the risk of dying from heart disease or stroke.
  • slows down the progression of chronic kidney disease.

The drug can be taken alone or with other anti-diabetes medicines.

Oral semaglutide vs. injection: main differences

Oral Rybelsus semaglutide is the first and only GLP-1 analogue available orally. It functions similarly to an injectable medication and has a cardiovascular safety profile that is comparable. In comparison to Ozempic, its primary disadvantage is that it must be taken daily, as opposed to weekly injections.

Tablets may have a slower rate of drug absorption than injections, which could mean that they have less of a therapeutic effect. Less bioavailability of the tablets may cause less weight loss than expected or less control over blood sugar levels. However, following the directions for semaglutide administration may prevent poor absorption:

  • The tablet must be taken on an empty stomach , swallowed whole, and washed down with a small amount of water,
  • then wait at least 30 minutes before eating or drinking anything.

It’s important to remember that how well semaglutide works, whether it’s taken by mouth or injected, depends on how you live. Therapy should include a proper diet and regular physical activity

Oral semaglutide – side effects

Tablets may have a slower rate of drug absorption than injections, which could mean that they have less of a therapeutic effect. Less bioavailability of the tablets may cause less weight loss than expected or less control over blood sugar levels. However, following the directions for semaglutide administration may prevent poor absorption:

  • progression of retinopathy (in people who already have changes in the fundus of the eye),
  • inflammation of the pancreas,
  • heartburn,
  • constipation,
  • tiredness,
  • loss of appetite or taste disturbances
  • allergy,
  • cholelithiasis,
  • tachycardia. 

It should also be remembered that although the drug is unlikely to pose a risk of hypoglycemia, the risk of hypoglycaemia is higher in people who are taking a drug containing a sulfonylurea or insulin at the same time. Therefore, in these cases, low sugar is a potential side effect. 

See also : Slimming injections : Do they work?